Bank of Nova Scotia
SGNT

Bank of Nova Scotia’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bank of Nova Scotia’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-66,572
Closed -$997K – 794
2016
Q2 		$997K Sell
66,572
-17,214
-21% -$221K 0.01% 369
2016
Q1 		$1.02M Buy
83,786
+24,414
+41% +$342K 0.01% 363
2015
Q4 		$945K Sell
59,372
-5,450
-8% -$85.8K ﹤0.01% 404
2015
Q3 		$994K Buy
+64,822
New +$1.4M 0.01% 319

Bank of Nova Scotia's SGNT Position: Q3 2016 in Review

Bank of Nova Scotia sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 66,572 shares — an estimated $997K sold.

Bank of Nova Scotia first reported a position in SGNT in Q3 2015 and held it in 4 quarters. The position peaked at $1.02M in Q1 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Bank of Nova Scotia reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Bank of Nova Scotia sold 66,572 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $997K.
  • Bank of Nova Scotia first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Bank of Nova Scotia's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.02M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Bank of Nova Scotia's 13F filing for Q3 2016, filed 14 Nov 2016.